{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:09:11Z","timestamp":1791202151030,"version":"4.2.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"12","content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.molmed.2013.08.006","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T00:46:26Z","timestamp":1379465186000},"page":"742-753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Common non-epigenetic drugs as epigenetic modulators"],"prefix":"10.1016","volume":"19","author":[{"given":"J\u00f6rn","family":"L\u00f6tsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisbert","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Reker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Parnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Geisslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Doehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2013.08.006_bib0005","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1126\/science.277.5332.1659","article-title":"Maternal care, hippocampal glucocorticoid receptors, and hypothalamic\u2013pituitary\u2013adrenal responses to stress","volume":"277","author":"Liu","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.molmed.2013.08.006_bib0010","first-page":"275","article-title":"Maternal programming of defensive responses through sustained effects on gene expression","volume":"32","author":"Diorio","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.molmed.2013.08.006_bib0015","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1146\/annurev.neuro.24.1.1161","article-title":"Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations","volume":"24","author":"Meaney","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.molmed.2013.08.006_bib0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4161\/epi.6.3.14378","article-title":"Physical activity and global genomic DNA methylation in a cancer-free population","volume":"6","author":"Zhang","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.molmed.2013.08.006_bib0025","doi-asserted-by":"crossref","first-page":"e1000602","DOI":"10.1371\/journal.pgen.1000602","article-title":"Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context","volume":"5","author":"Christensen","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molmed.2013.08.006_bib0030","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nature10093","article-title":"Royalactin induces queen differentiation in honeybees","volume":"473","author":"Kamakura","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2013.08.006_bib0035","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1158\/0008-5472.CAN-06-2995","article-title":"Changes in DNA methylation patterns in subjects exposed to low-dose benzene","volume":"67","author":"Bollati","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2013.08.006_bib0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd1930","article-title":"Epigenetic therapy of cancer: past, present and future","volume":"5","author":"Yoo","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2013.08.006_bib0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2013.08.006_bib0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrrheum.2012.237","article-title":"Genetics and epigenetics of rheumatoid arthritis","volume":"9","author":"Viatte","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejpain.2010.06.004","article-title":"Epigenetics in pain and analgesia: an imminent research field","volume":"15","author":"Doehring","year":"2011","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.molmed.2013.08.006_bib0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.neuron.2012.01.012","article-title":"Chronic pain: emerging evidence for the involvement of epigenetics","volume":"73","author":"Denk","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.molmed.2013.08.006_bib0065","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.mehy.2008.10.039","article-title":"Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology","volume":"73","author":"Csoka","year":"2009","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.molmed.2013.08.006_bib0070","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2013.08.006_bib0075","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1074\/jbc.M707964200","article-title":"Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner","volume":"283","author":"Paradisi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2013.08.006_bib0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pain.2012.06.011","article-title":"Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain","volume":"154","author":"Doehring","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.molmed.2013.08.006_bib0085","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2013.08.006_bib0090","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.clml.2012.01.005","article-title":"Epigenetic therapy with hydralazine and magnesium valproate reverses imatinib resistance in patients with chronic myeloid leukemia","volume":"12","author":"Cervera","year":"2012","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.molmed.2013.08.006_bib0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/15376516.2011.557883","article-title":"Epigenetic screening in product safety assessment: are we there yet?","volume":"21","author":"Rasoulpour","year":"2011","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.molmed.2013.08.006_bib0100","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2013.08.006_bib0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10555-008-9118-y","article-title":"Demethylation of (cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development","volume":"27","author":"Patra","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.molmed.2013.08.006_bib0110","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/bies.201000057","article-title":"Mammalian methyl-binding proteins: what might they do?","volume":"32","author":"Joulie","year":"2010","journal-title":"Bioessays"},{"key":"10.1016\/j.molmed.2013.08.006_bib0115","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s00018-008-8432-4","article-title":"Epigenetic mechanisms in mammals","volume":"66","author":"Kim","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.molmed.2013.08.006_bib0120","doi-asserted-by":"crossref","first-page":"33002","DOI":"10.1074\/jbc.274.46.33002","article-title":"Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation","volume":"274","author":"Pradhan","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2013.08.006_bib0125","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2013.08.006_bib0130","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/nar\/10.8.2709","article-title":"Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells","volume":"10","author":"Ehrlich","year":"1982","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2013.08.006_bib0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/321209a0","article-title":"CpG-rich islands and the function of DNA methylation","volume":"321","author":"Bird","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2013.08.006_bib0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.molmed.2013.08.006_bib0145","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1515\/BC.2009.131","article-title":"The epigenetic bottleneck of neurodegenerative and psychiatric diseases","volume":"390","author":"Sananbenesi","year":"2009","journal-title":"Biol. Chem."},{"key":"10.1016\/j.molmed.2013.08.006_bib0150","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev-genet-110711-155451","article-title":"5-Methylcytosine DNA demethylation: more than losing a methyl group","volume":"46","author":"Franchini","year":"2012","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.molmed.2013.08.006_bib0155","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.cell.2011.08.042","article-title":"DNA demethylation dynamics","volume":"146","author":"Bhutani","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2013.08.006_bib0160","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2013.08.006_bib0165","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/sj.onc.1210618","article-title":"Structure and acetyl-lysine recognition of the bromodomain","volume":"26","author":"Mujtaba","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2013.08.006_bib0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.biochem.70.1.81","article-title":"Histone acetyltransferases","volume":"70","author":"Roth","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.molmed.2013.08.006_bib0175","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H","article-title":"Roles of histone acetyltransferases and deacetylases in gene regulation","volume":"20","author":"Kuo","year":"1998","journal-title":"Bioessays"},{"key":"10.1016\/j.molmed.2013.08.006_bib0180","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1126\/science.1153069","article-title":"Nutritional control of reproductive status in honeybees via DNA methylation","volume":"319","author":"Kucharski","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.molmed.2013.08.006_bib0185","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/embor.2011.9","article-title":"Histone deacetylase inhibitor activity in royal jelly might facilitate caste switching in bees","volume":"12","author":"Spannhoff","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molmed.2013.08.006_bib0190","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","article-title":"The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?","volume":"64","author":"Rosenberg","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.molmed.2013.08.006_bib0195","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1158\/0008-5472.CAN-04-2478","article-title":"Valproic acid alters chromatin structure by regulation of chromatin modulation proteins","volume":"65","author":"Marchion","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2013.08.006_bib0200","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.4049\/jimmunol.140.7.2197","article-title":"Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity","volume":"140","author":"Cornacchia","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1479-5876-4-10","article-title":"Hydralazine target: from blood vessels to the epigenome","volume":"4","author":"Arce","year":"2006","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.molmed.2013.08.006_bib0210","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/cmdc.200900017","article-title":"Molecular modeling and molecular dynamics studies of hydralazine with human DNA methyltransferase 1","volume":"4","author":"Singh","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.molmed.2013.08.006_bib0215","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00277-010-1090-2","article-title":"Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial","volume":"90","author":"Candelaria","year":"2011","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0220","doi-asserted-by":"crossref","first-page":"e14060","DOI":"10.1371\/journal.pone.0014060","article-title":"Gemcitabine functions epigenetically by inhibiting repair mediated DNA demethylation","volume":"5","author":"Schafer","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2013.08.006_bib0225","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.dnarep.2011.04.022","article-title":"Regulation of endonuclease activity in human nucleotide excision repair","volume":"10","author":"Fagbemi","year":"2011","journal-title":"DNA Repair (Amst.)"},{"key":"10.1016\/j.molmed.2013.08.006_bib0230","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature05515","article-title":"Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation","volume":"445","author":"Barreto","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2013.08.006_bib0235","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/npp.2008.108","article-title":"Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts","volume":"34","author":"Nielsen","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2013.08.006_bib0240","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.1089670","article-title":"Mobile elements: drivers of genome evolution","volume":"303","author":"Kazazian","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.molmed.2013.08.006_bib0245","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature10531","article-title":"Somatic retrotransposition alters the genetic landscape of the human brain","volume":"479","author":"Baillie","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2013.08.006_bib0250","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1073\/pnas.1106103108","article-title":"Serotonin, cytokines, p11, and depression","volume":"108","author":"Snyder","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.08.006_bib0255","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1073\/pnas.1104836108","article-title":"Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans","volume":"108","author":"Warner-Schmidt","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.08.006_bib0260","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.brainresbull.2009.01.006","article-title":"Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders","volume":"79","author":"Dell\u2019aversano","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.molmed.2013.08.006_bib0265","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(01)00989-X","article-title":"Fluoxetine increases the content of neurotrophic protein S100\u03b2 in the rat hippocampus","volume":"420","author":"Manev","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.coph.2006.10.001","article-title":"p11 (S100A10) \u2013 an inducible adaptor protein that modulates neuronal functions","volume":"7","author":"Svenningsson","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0275","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.1117571","article-title":"Alterations in 5-HT1B receptor function by p11 in depression-like states","volume":"311","author":"Svenningsson","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.molmed.2013.08.006_bib0280","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neulet.2008.09.063","article-title":"Association study of p11 gene with major depressive disorder, suicidal behaviors and treatment response","volume":"447","author":"Tzang","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molmed.2013.08.006_bib0285","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1017\/S1461145711000940","article-title":"Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression","volume":"15","author":"Melas","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0290","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-4419-8216-2_9","article-title":"A new epigenetic challenge: systemic lupus erythematosus","volume":"711","author":"Javierre","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0295","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/carcin\/bgh209","article-title":"Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-\u03b1 gene in rat colon tumors","volume":"25","author":"Pereira","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.molmed.2013.08.006_bib0300","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/jnci\/djj206","article-title":"Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors","volume":"98","author":"Grosch","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.molmed.2013.08.006_bib0305","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00109-009-0506-8","article-title":"Cellular membranes function as a storage compartment for celecoxib","volume":"87","author":"Maier","year":"2009","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.molmed.2013.08.006_bib0310","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/onc.2011.308","article-title":"Phosphorylation of RelA\/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1","volume":"31","author":"Liu","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2013.08.006_bib0315","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.bcp.2008.06.015","article-title":"Celecoxib potently inhibits TNF\u03b1-induced nuclear translocation and activation of NF-\u03baB","volume":"76","author":"Funakoshi-Tago","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0320","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1096\/fj.00-0716fje","article-title":"Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-\u03baB","volume":"15","author":"Niederberger","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.molmed.2013.08.006_bib0325","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/187152009787047752","article-title":"Tyrosine kinase blockers: new hope for successful cancer therapy","volume":"9","author":"Pytel","year":"2009","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.molmed.2013.08.006_bib0330","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2013.08.006_bib0335","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drup.2005.04.005","article-title":"Resistance to tyrosine kinase inhibitors: calling on extra forces","volume":"8","author":"Cools","year":"2005","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.molmed.2013.08.006_bib0340","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1038\/leu.2010.145","article-title":"Long-term exposure of leukemia cells to multi-targeted tyrosine kinase inhibitor induces activations of AKT, ERK and STAT5 signaling via epigenetic silencing of the PTEN gene","volume":"24","author":"Nishioka","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.molmed.2013.08.006_bib0345","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1038\/bcj.2011.33","article-title":"Imatinib causes epigenetic alterations of PTEN gene via upregulation of DNA methyltransferases and polycomb group proteins","volume":"1","author":"Nishioka","year":"2011","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.molmed.2013.08.006_bib0350","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nature04431","article-title":"The polycomb group protein EZH2 directly controls DNA methylation","volume":"439","author":"Vire","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2013.08.006_bib0355","doi-asserted-by":"crossref","first-page":"e40466","DOI":"10.1371\/journal.pone.0040466","article-title":"Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancer","volume":"7","author":"Stone","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2013.08.006_bib0360","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/neu.2010.1648","article-title":"Fluoxetine increases hippocampal neurogenesis and induces epigenetic factors but does not improve functional recovery after traumatic brain injury","volume":"28","author":"Wang","year":"2011","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.molmed.2013.08.006_bib0365","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/mol.106.022301","article-title":"Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain","volume":"70","author":"Cassel","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0370","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/30764","article-title":"Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex","volume":"393","author":"Nan","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2013.08.006_bib0375","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/561","article-title":"Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription","volume":"19","author":"Jones","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2013.08.006_bib0380","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1126\/science.1179438","article-title":"Essential role of the histone methyltransferase G9a in cocaine-induced plasticity","volume":"327","author":"Maze","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.molmed.2013.08.006_bib0385","doi-asserted-by":"crossref","first-page":"17454","DOI":"10.1523\/JNEUROSCI.1357-12.2012","article-title":"Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus accumbens","volume":"32","author":"Sun","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2013.08.006_bib0390","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.molonc.2012.09.003","article-title":"HDAC inhibitor-based therapies: Can we interpret the code?","volume":"6","author":"New","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0395","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1002\/(SICI)1521-3773(19991004)38:19<2894::AID-ANIE2894>3.0.CO;2-F","article-title":"\u2018Scaffold hopping\u2019 by topological pharmacophore search: a contribution to virtual screening","volume":"38","author":"Schneider","year":"1999","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.molmed.2013.08.006_bib0400","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/minf.201200141","article-title":"Chemically advanced template search (CATS) for scaffold-hopping and prospective target prediction for \u2018orphan\u2019 molecules","volume":"32","author":"Reutlinger","year":"2013","journal-title":"Mol. Inform."},{"key":"10.1016\/j.molmed.2013.08.006_bib0405","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/qsar.200330825","article-title":"Collection of bioactive reference compounds for focused library design","volume":"22","author":"Schneider","year":"2003","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.molmed.2013.08.006_bib0410","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF00337288","article-title":"Self-organized formation of topologically correct feature maps","volume":"43","author":"Kohonen","year":"1982","journal-title":"Biol. Cybernet."},{"key":"10.1016\/j.molmed.2013.08.006_bib0415","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4155\/fmc.09.11","article-title":"Self-organizing molecular fingerprints: a ligand-based view on drug-like chemical space and off-target prediction","volume":"1","author":"Schneider","year":"2009","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.molmed.2013.08.006_bib0420","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/092986709787002655","article-title":"Self-organizing maps in drug discovery: compound library design, scaffold-hopping, repurposing","volume":"16","author":"Schneider","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.molmed.2013.08.006_bib0425","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry","volume":"25","author":"Keiser","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0430","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature11159","article-title":"Large-scale prediction and testing of drug activity on side-effect targets","volume":"486","author":"Lounkine","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2013.08.006_bib0435","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10629360601054032","article-title":"PASS: identification of probable targets and mechanisms of toxicity","volume":"18","author":"Poroikov","year":"2007","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.molmed.2013.08.006_bib0440","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cbpa.2008.03.015","article-title":"Coverage and bias in chemical library design","volume":"12","author":"Gregori-Puigjane","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0445","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1021\/ci100010v","article-title":"When is chemical similarity significant? The statistical distribution of chemical similarity scores and its extreme values","volume":"50","author":"Baldi","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.molmed.2013.08.006_bib0450","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: a large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2013.08.006_bib0455","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.bmcl.2005.01.024","article-title":"N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP","volume":"15","author":"Rossello","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.molmed.2013.08.006_bib0460","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1517\/14728220903241658","article-title":"Targeting of HDAC8 and investigational inhibitors in neuroblastoma","volume":"18","author":"Oehme","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.molmed.2013.08.006_bib0465","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1101\/gad.1809209","article-title":"Epigenetic control of skull morphogenesis by histone deacetylase 8","volume":"23","author":"Haberland","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2013.08.006_bib0470","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1210\/me.2009-0441","article-title":"An acetylation switch modulates the transcriptional activity of estrogen-related receptor \u03b1","volume":"24","author":"Wilson","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0475","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/bip.22135","article-title":"HDAC8 substrates: histones and beyond","volume":"99","author":"Wolfson","year":"2013","journal-title":"Biopolymers"},{"key":"10.1016\/j.molmed.2013.08.006_bib0480","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mce.2011.10.004","article-title":"Environmentally induced epigenetic transgenerational inheritance of phenotype and disease","volume":"354","author":"Guerrero-Bosagna","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0485","doi-asserted-by":"crossref","first-page":"e41143","DOI":"10.1371\/journal.pone.0041143","article-title":"Transgenerational inheritance of modified DNA methylation patterns and enhanced tolerance induced by heavy metal stress in rice (Oryza sativa L.)","volume":"7","author":"Ou","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2013.08.006_bib0490","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.biopsych.2010.05.036","article-title":"Epigenetic transmission of the impact of early stress across generations","volume":"68","author":"Franklin","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2013.08.006_bib0495","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa064522","article-title":"Inheritance of a cancer-associated MLH1 germ-line epimutation","volume":"356","author":"Hitchins","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2013.08.006_bib0500","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.diabres.2008.12.018","article-title":"Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study","volume":"83","author":"Agrawal","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.molmed.2013.08.006_bib0505","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/13543784.16.7.1111","article-title":"Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma","volume":"16","author":"Duvic","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.molmed.2013.08.006_bib0510","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1200\/JCO.2011.41.2395","volume":"30","author":"Yeo","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0515","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2141.2010.08266.x","article-title":"A pilot study of the histone-deacetylase inhibitor givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms","volume":"150","author":"Rambaldi","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2013.08.006_bib0520","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/art.30238","article-title":"Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis","volume":"63","author":"Vojinovic","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molmed.2013.08.006_bib0525","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1586\/era.10.88","article-title":"Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors","volume":"10","author":"Grant","year":"2010","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.molmed.2013.08.006_bib0530","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/bjc.2011.527","article-title":"Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours","volume":"106","author":"Pili","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.molmed.2013.08.006_bib0535","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1358\/dot.2007.43.6.1062666","article-title":"DNA methyltransferases as targets for cancer therapy","volume":"43","author":"Ghoshal","year":"2007","journal-title":"Drugs Today (Barc.)"},{"key":"10.1016\/j.molmed.2013.08.006_bib0540","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1073\/pnas.1015483108","article-title":"Cocaine dynamically regulates heterochromatin and repetitive element unsilencing in nucleus accumbens","volume":"108","author":"Maze","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2013.08.006_bib0545","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s13238-010-0037-7","article-title":"Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site","volume":"1","author":"Abuhammad","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.molmed.2013.08.006_bib0550","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.bmc.2009.11.050","article-title":"Novel and selective DNA methyltransferase inhibitors: docking-based virtual screening and experimental evaluation","volume":"18","author":"Kuck","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.molmed.2013.08.006_bib0555","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jmgm.2011.12.006","article-title":"Nonlinear dimensionality reduction and mapping of compound libraries for drug discovery","volume":"34","author":"Reutlinger","year":"2012","journal-title":"J. Mol. Graph. Model."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491413001494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491413001494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:55:36Z","timestamp":1715972136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491413001494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":111,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1471491413001494"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2013.08.006","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Common non-epigenetic drugs as epigenetic modulators","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2013.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}